| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Tarsus Pharmaceuticals, Inc. (TARS) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 17 sells. TARS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 858.5K | $52.55M | - | |
| Dir | 128.8K | $7.89M | - | |
| COO | 79.2K | $4.85M | - | |
| Other | 47.6K | $2.91M | - | |
| Other | 36.7K | $2.25M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 1, 2022 | Whitfield Dianne C. | Chief Human Resources Officer | Sale+OE | 2,347 | $16.62 | $39,016.75 | -10.1% | -9.3% | -6.2% | |
| Dec 1, 2022 | Wahl Bryan | General Counsel | Sale+OE | 2,347 | $16.62 | $39,016.50 | -7.1% | -9.3% | -6.2% | |
| Nov 17, 2022 | Greenstein Leonard M. | Chief Financial Officer | Sell | 5,000 | $16.54 | $82,700.00 | -9.2% | -6.7% | +14.7% | |
| Nov 16, 2022 | Azamian Bobak R.45 | President And CEO | Sell | 8,000 | $16.86 | $134,852.50 | -0.3% | -8.8% | +5.0% | |
| Nov 15, 2022 | Mottiwala Aziz51 | Chief Commercial Officer | Sell | 6,857 | $17.72 | $121,506.04 | -12.1% | -15.1% | +0.7% | |
| Nov 9, 2022 | Azamian Bobak R.45 | President And CEO | Sell | 9,000 | $17.87 | $160,830.00 | -0.8% | -11.9% | -12.4% | |
| Oct 20, 2022 | Greenstein Leonard M. | Chief Financial Officer | Sell | 5,000 | $15.92 | $79,588.56 | -4.4% | -8.2% | -17.2% | |
| Oct 19, 2022 | Azamian Bobak R.45 | President And CEO | Sell | 8,000 | $16.92 | $135,349.00 | -0.3% | -14.0% | -22.8% | |
| Oct 12, 2022 | Azamian Bobak R.45 | President And CEO | Sell | 9,000 | $15.91 | $143,194.08 | -0.4% | -6.2% | -7.5% | |
| Sep 21, 2022 | Azamian Bobak R.45 | President And CEO | Sell | 8,000 | $16.31 | $130,474.50 | -0.3% | -10.4% | +4.1% |